The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
Many reproductive-age women seek health information through online sources, where they may encounter false or misleading information about contraception, according to the 2026 KFF Women’s Health Survey. And an Ohio health department’s new AI policy offers a rare example of a health-specific policy addressing accuracy and public trust.
This brief presents findings from KFF's 2026 Women's Health Survey and offers an early look at how the information that women encounter online through social media translates into real-world decision about their contraceptive care. It also looks at exposure to false or misleading claims women encounter about contraception.
The contraceptive implant is the most effective method of birth control available, and while it’s use is still low compared to other methods, its provision and use are increasing.
In this analysis, published in the journal Contraception, KFF’s Linda Li, Brittni Frederiksen, and Alina Salganicoff look at intrauterine device (IUD) and contraceptive implant insertion-related costs among privately insured individuals to better understand why patients are experiencing unexpected expenses for what should be fully covered contraceptive services under the ACA.
Authored by KFF’s Alina Salganicoff, Ivette Gomez, and Usha Ranji, this article for The Milbank Quarterly examines how state policies create varying levels of access to reproductive healthcare services.
This brief provides an update on Planned Parenthood closures and participation in the Title X program in the midst of substantial policy changes leading to decreased funding for Planned Parenthood including the One Big Beautiful Bill Act and the withholding of federal Title X funding to Planned Parenthood clinics.
Five technology companies have launched dedicated consumer-facing AI health tools so far in 2026, reflecting though questions about AI’s reliability remain. And a decades-old WHO classification has been misrepresented online to suggest that hormonal birth control pills were recently found to cause cancer.
This brief provides an overview of oral contraception, discusses private insurance and Medicaid coverage, and reviews strategies to promote and expand women’s access to oral contraceptives.
Oral contraceptives are the most commonly used method of reversible contraception in the U.S. In July 2023, the FDA approved Opill, the first daily oral contraceptive pill to become available over the counter (OTC) without a doctor’s prescription. This issue brief provides an overview of OTC oral contraceptives and laws and policies related to insurance coverage.
© 2026 KFF